These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 8862764

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Enhanced expression of urokinase-type plasminogen activator in the rat endometrium following induction of decidualisation.
    Tarachand U, Pawse AR.
    Indian J Exp Biol; 1994 May; 32(5):304-6. PubMed ID: 7927520
    [Abstract] [Full Text] [Related]

  • 4. Effects of thrombin on steroid-modulated cultured endometrial stromal cell fibrinolytic potential.
    Lockwood CJ, Krikun G, Aigner S, Schatz F.
    J Clin Endocrinol Metab; 1996 Jan; 81(1):107-12. PubMed ID: 8550736
    [Abstract] [Full Text] [Related]

  • 5. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression.
    Lockwood CJ, Krikun G, Papp C, Aigner S, Schatz F.
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1100-5. PubMed ID: 7714076
    [Abstract] [Full Text] [Related]

  • 6. Localization and distribution of tissue type and urokinase type plasminogen activators and their inhibitors Type 1 and 2 in human and rhesus monkey fetal membranes.
    Liu YX, Hu ZY, Liu K, Byrne S, Zou RJ, Ny T, d'Lacey C, Ockleford CD.
    Placenta; 1998 Apr; 19(2-3):171-80. PubMed ID: 9548184
    [Abstract] [Full Text] [Related]

  • 7. Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle.
    Nordengren J, Pilka R, Noskova V, Ehinger A, Domanski H, Andersson C, Høyer-Hansen G, Hansson SR, Casslén B.
    Mol Hum Reprod; 2004 Sep; 10(9):655-63. PubMed ID: 15243126
    [Abstract] [Full Text] [Related]

  • 8. Dedifferentiation of serous ovarian cancer from cystic to solid tumors is associated with increased expression of mRNA for urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor (PAI-1).
    Borgfeldt C, Hansson SR, Gustavsson B, Måsbäck A, Casslén B.
    Int J Cancer; 2001 May 15; 92(4):497-502. PubMed ID: 11304683
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Expression of tissue type and urokinase type plasminogen activators as well as plasminogen activator inhibitor type-1 and type-2 in human and rhesus monkey placenta.
    Hu ZY, Liu YX, Liu K, Byrne S, Ny T, Feng Q, Ockleford CD.
    J Anat; 1999 Feb 15; 194 ( Pt 2)(Pt 2):183-95. PubMed ID: 10337950
    [Abstract] [Full Text] [Related]

  • 11. Differential mRNA expression of urokinase-type plasminogen activator, plasminogen activator receptor and plasminogen activator inhibitor type-2 in normal human endometria and endometrial carcinomas.
    Foca C, Moses EK, Quinn MA, Rice GE.
    Gynecol Oncol; 2000 Nov 15; 79(2):244-50. PubMed ID: 11063652
    [Abstract] [Full Text] [Related]

  • 12. Embryo implantation in mouse: fetomaternal coordination in the pattern of expression of uPA, uPAR, PAI-1 and alpha 2MR/LRP genes.
    Teesalu T, Blasi F, Talarico D.
    Mech Dev; 1996 May 15; 56(1-2):103-16. PubMed ID: 8798151
    [Abstract] [Full Text] [Related]

  • 13. Effect of transforming growth factor-beta on the plasminogen activator system in cultured first trimester human cytotrophoblasts.
    Graham CH.
    Placenta; 1997 May 15; 18(2-3):137-43. PubMed ID: 9089774
    [Abstract] [Full Text] [Related]

  • 14. Regulation of plasminogen activator inhibitor 1 expression by interaction of epidermal growth factor with progestin during decidualization of human endometrial stromal cells.
    Lockwood CJ.
    Am J Obstet Gynecol; 2001 Apr 15; 184(5):798-804; discussion 804-5. PubMed ID: 11303186
    [Abstract] [Full Text] [Related]

  • 15. Expression and function of the urokinase type plasminogen activator during mouse hemochorial placental development.
    Teesalu T, Blasi F, Talarico D.
    Dev Dyn; 1998 Sep 15; 213(1):27-38. PubMed ID: 9733098
    [Abstract] [Full Text] [Related]

  • 16. Progestin regulation of plasminogen activator inhibitor type 1 in primary cultures of endometrial stromal and decidual cells.
    Schatz F, Lockwood CJ.
    J Clin Endocrinol Metab; 1993 Sep 15; 77(3):621-5. PubMed ID: 8370684
    [Abstract] [Full Text] [Related]

  • 17. Expression of plasminogen activator inhibitors type 1 and type 3 and urokinase plasminogen activator protein and mRNA in breast cancer.
    Castelló R, Landete JM, España F, Vázquez C, Fuster C, Almenar SM, Ramón LA, Radtke KP, Estellés A.
    Thromb Res; 2007 Sep 15; 120(5):753-62. PubMed ID: 17258797
    [Abstract] [Full Text] [Related]

  • 18. Secretion of plasminogen activator by cultured rat endometrial stromal cells from uteri differentially sensitized for the decidual cell reaction.
    Kennedy TG, Ross HE, Barbe GJ, Shu MA, Zhang X.
    Mol Reprod Dev; 1998 Mar 15; 49(3):268-76. PubMed ID: 9491379
    [Abstract] [Full Text] [Related]

  • 19. Plasminogen activators and inhibitors are transcribed during early macaque implantation.
    Feng Q, Liu K, Liu YX, Byrne S, Ockleford CD.
    Placenta; 2001 Mar 15; 22(2-3):186-99. PubMed ID: 11170823
    [Abstract] [Full Text] [Related]

  • 20. Coordinated expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 during corpus luteum formation and luteolysis in the adult pseudopregnant rat.
    Liu K, Brändström A, Liu YX, Ny T, Selstam G.
    Endocrinology; 1996 May 15; 137(5):2126-32. PubMed ID: 8612557
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.